Ever since its discovery, cannabidiol (CBD) has made waves throughout both the medical cannabis and nutrition industries; however, it’s that latter for whom this product has been a bit of a headache.
The 2014 Farm Bill helped bring mainstream CBD products to consumers by defining industrial hemp as anything containing 0.3% THC or less; however, despite this bill, hemp’s membership in the cannabis family technically still makes it a Schedule 1 controlled substance by the DEA. In other words, it’s legal and illegal at the same time. Medical marijuana suffers from a similar conundrum, being legalized in some states but still illegal federally, leading to DEA raids on legitimate dispensaries. Naturally, producers of hemp-derived CBD don’t want to run into that legal mess.
The Hemp Farm Act of 2018 seeks to change that. Aside from once again clarifying that anything at or below the 0.3% THC threshold is industrial hemp, it also removes hemp from the DEA’s list of Schedule 1 drugs. In short, producers of oils, tinctures, foods, vape products and other hemp items will breathe easy, knowing that their businesses won’t face potential run-ins with law enforcement.
A bi-partisan bill introduced by Republican Mitch McConnell (R-Kentucky) and co-sponsored by Ron Wyden (D-Oregon) and Rand Paul (R-Kentucky), the Hemp Farm Act of 2018 has the potential to create thousands of jobs and businesses while offering a new option for health-conscious consumers.
The Hemp Farm Act of 2018 was introduced on April 12th and hopes are high that it will succeed, both for CBD advocates and the economy.